The comparison of total body irradiation vs chlorambucil and prednisone for remission induction of active chronic lymphocytic leukemia: an ecog study Part : Total body irradiation—Response and toxicity-Reference-Cited by-同舟云学术

The comparison of total body irradiation vs chlorambucil and prednisone for remission induction of active chronic lymphocytic leukemia: an ecog study Part : Total body irradiation—Response and toxicity

Published:1981-12 Issue:12 Volume:7 Page:1623-1632
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Rubin Philip,Bennett John M.,Begg Colin,Bozdech Marek J.,Silber Robert

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference25 articles.

1. Chronic lymphocytic leukemia: Therapeutic options;Bennett;Int. J. Radiat. Oncol. Biol. Phys.,1976

2. Factors influencing the duration of survival of patients with chronic lymphocytic leukemia;Boggs;Am. J. Med.,1966

3. Proposed guidelines for Protocol Studies III. Chronic lymphocytic leukemia;Chronic Leukemia-Myeloma Task Force;Can. Chemo. Rep.,1973

4. Proliferative activity of stem cells in the bone-marrow of mice after single and multiple irradiations (total- or partial-body exposure);Croizat;Int. J. Radiat. Biol.,1970

5. Total body irradiation in the treatment of chronic lymphogenous leukemia;del Regato;Am. J. Roentgenol.,1974

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-Dose Hemibody Radiation, a Treatment Option for Recurrent Prostate Cancer: A Phase 2 Single-Arm Trial;Advances in Radiation Oncology;2023-01

2. Radionuclide Therapy of Leukemias and Multiple Myeloma;Nuclear Oncology;2022

3. Radionuclide Therapy of Leukemias and Multiple Myeloma;Nuclear Oncology;2022

4. Hematological Changes Following Low Dose Radiation Therapy and Comparison to Current Standard of Care Cancer Treatments;Dose-Response;2021-10

5. Time to rejuvenate ultra-low dose whole-body radiotherapy of cancer;Critical Reviews in Oncology/Hematology;2021-04